Headlines about Blackrock Health Sciences Trust (NYSE:BME) have trended positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of 0.49 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.5554882457266 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Shares of Blackrock Health Sciences Trust (BME) traded up $0.20 during midday trading on Wednesday, hitting $36.21. 2,138 shares of the stock traded hands, compared to its average volume of 44,177. Blackrock Health Sciences Trust has a 1-year low of $32.81 and a 1-year high of $38.00.
The business also recently announced a monthly dividend, which will be paid on Thursday, March 29th. Stockholders of record on Thursday, March 15th will be given a $0.20 dividend. The ex-dividend date is Wednesday, March 14th. This represents a $2.40 annualized dividend and a dividend yield of 6.63%.
BlackRock Health Sciences Trust is a non-diversified, closed-end management investment company (the Trust). The Trust’s investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.